Clinical Trial: Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07665892) titled 'Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma' on May 27.

Brief Summary: This is a phase 1 study, randomized, double-blind, placebo-controlled, 2 treatment, 2 period crossover study to evaluate the pharmacokinetics, safety, and tolerability of a single inhaled dose of ASY202 in adults with stable asthma.

Following screening, eligible participants will be enrolled and randomized to one of two treatment sequences. Participants will receive a single inhaled dose of ASY202 and a single inhaled dose of placebo, each administered once during separate study periods.

During each treatment period, sub...